Comparison of Symptoms Associated With SARS-CoV-2 Variants Among Children in Canada

Author:

Sumner Madeleine W.1,Xie Jianling2,Zemek Roger34,Winston Kathleen5,Freire Gabrielle6,Burstein Brett78,Kam April9,Emsley Jason10,Gravel Jocelyn11,Porter Robert12,Sabhaney Vikram13,Mater Ahmed14,Salvadori Marina I.1516,Berthelot Simon17,Beer Darcy18,Poonai Naveen192021,Moffatt Anne22,Wright Bruce23,Freedman Stephen B.24,Ali Samina25,Newton Mandi25,Alqurashi Waleed25,Lorenzo Melissa25,Crawford Tyrus25,Emerton Becky25,

Affiliation:

1. Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada

2. Section of Pediatric Emergency Medicine, Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

3. Department of Pediatrics, University of Ottawa, Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada

4. Department of Emergency Medicine, University of Ottawa, Children’s Hospital of Eastern Ontario, Ottawa, Ontario, Canada

5. Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

6. Division of Emergency Medicine, Department of Paediatrics, Hospital for Sick Children, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada

7. Division of Pediatric Emergency Medicine, Department of Pediatrics, Montreal Children’s Hospital, McGill University Health Centre, Montreal, Quebec, Canada

8. Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada

9. Division of Emergency Medicine, Department of Pediatrics, McMaster Children’s Hospital, Hamilton, Ontario, Canada

10. Department of Emergency Medicine, IWK Children’s Health Centre and Queen Elizabeth II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada

11. Department of Pediatric Emergency Medicine, Centre Hospitalier Universitaire (CHU) Sainte-Justine, Université de Montréal, Montreal, Quebec, Canada

12. Janeway Children’s Health and Rehabilitation Centre, Eastern Health, St John’s, Newfoundland and Labrador, Canada

13. Department of Paediatrics, BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada

14. Section of Pediatric Emergency, Department of Pediatrics, Jim Pattison Children’s Hospital, University of Saskatchewan, Saskatoon, Saskatchewan, Canada

15. Public Health Agency of Canada, Ottawa, Ontario, Canada

16. Department of Pediatrics, McGill University, Montreal, Quebec, Canada

17. Département de Médecine Familiale et de Médecine d’Urgence, CHU de Québec-Université, Québec City, Quebec, Canada

18. Department of Pediatrics and Child Health, The Children’s Hospital of Winnipeg, Children’s Hospital Research Institute of Manitoba, University of Manitoba, Winnipeg, Canada

19. Department of Paediatrics, Children’s Hospital London Health Sciences Centre, Schulich School of Medicine & Dentistry, London, Ontario, Canada

20. Department of Internal Medicine, Children’s Hospital London Health Sciences Centre, Schulich School of Medicine & Dentistry, London, Ontario, Canada

21. Department of Epidemiology & Biostatistics, Children’s Hospital London Health Sciences Centre, Schulich School of Medicine & Dentistry, London, Ontario, Canada

22. Department of Paediatrics, Kingston Health Sciences Centre, Queen’s University, Kingston, Ontario, Canada

23. University of Alberta, Department of Pediatrics, Stollery Children’s Hospital, Edmonton, Alberta, Canada

24. Sections of Pediatric Emergency Medicine and Gastroenterology, Departments of Pediatrics and Emergency Medicine, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

25. for the Pediatric Emergency Research Canada (PERC) COVID Study Group

Abstract

ImportanceClinical manifestations of SARS-CoV-2 variants have not been systematically compared in children.ObjectiveTo compare symptoms, emergency department (ED) chest radiography, treatments, and outcomes among children with different SARS-CoV-2 variants.Design, Setting, and ParticipantsThis multicenter cohort study was performed at 14 Canadian pediatric EDs. Participants included children and adolescents younger than 18 years (hereinafter referred to as children) tested for SARS-CoV-2 infection in an ED between August 4, 2020, and February 22, 2022, with 14 days of follow-up.Exposure(s)SARS-CoV-2 variants detected on a specimen collected from the nasopharynx, nares, or throat.Main Outcomes and MeasuresThe primary outcome was presence and number of presenting symptoms. The secondary outcomes were presence of core COVID-19 symptoms, chest radiography findings, treatments, and 14-day outcomes.ResultsAmong 7272 participants presenting to an ED, 1440 (19.8%) had test results positive for SARS-CoV-2 infection. Of these, 801 (55.6%) were boys, with a median age of 2.0 (IQR, 0.6-7.0) years. Children with the Alpha variant reported the fewest core COVID-19 symptoms (195 of 237 [82.3%]), which were most often reported by participants with Omicron variant infection (434 of 468 [92.7%]; difference, 10.5% [95% CI, 5.1%-15.9%]). In a multivariable model with the original type as the referent, the Omicron and Delta variants were associated with fever (odds ratios [ORs], 2.00 [95% CI, 1.43-2.80] and 1.93 [95% CI, 1.33-2.78], respectively) and cough (ORs, 1.42 [95% CI, 1.06-1.91] and 1.57 [95% CI, 1.13-2.17], respectively). Upper respiratory tract symptoms were associated with Delta infection (OR, 1.96 [95% CI, 1.38-2.79]); lower respiratory tract and systemic symptoms were associated with Omicron variant infection (ORs, 1.42 [95% CI, 1.04-1.92] and 1.77 [95% CI, 1.24-2.52], respectively). Children with Omicron infection most often had chest radiography performed and received treatments; compared with those who had Delta infection, they were more likely to have chest radiography performed (difference, 9.7% [95% CI, 4.7%-14.8%]), to receive intravenous fluids (difference, 5.6% [95% CI, 1.0%-10.2%]) and corticosteroids (difference, 7.9% [95% CI, 3.2%-12.7%]), and to have an ED revisit (difference, 8.8% [95% CI, 3.5%-14.1%]). The proportions of children admitted to the hospital and intensive care unit did not differ between variants.Conclusions and RelevanceThe findings of this cohort study of SARS-CoV-2 variants suggest that the Omicron and Delta variants were more strongly associated with fever and cough than the original-type virus and the Alpha variant. Children with Omicron variant infection were more likely to report lower respiratory tract symptoms and systemic manifestations, undergo chest radiography, and receive interventions. No differences were found in undesirable outcomes (ie, hospitalization, intensive care unit admission) across variants.

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3